Published in Psychopharmacology (Berl) on May 15, 2015
Immune influences on the brain: new findings and implications for treatment. Psychopharmacology (Berl) (2016) 0.75
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med (2004) 16.21
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry (2009) 8.74
Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49
Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature (2005) 6.21
Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med (2008) 3.10
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry (2009) 2.36
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15
The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology (2006) 2.12
A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry (2002) 1.73
Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry (2008) 1.73
Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A (2001) 1.68
Innate immunity in the liver. Curr Opin Gastroenterol (2003) 1.38
Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology (2012) 1.28
Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry (2012) 1.28
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clin Infect Dis (2012) 1.20
A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun (2012) 1.17
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology (2012) 1.06
Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry (2014) 1.02
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. Eur Neuropsychopharmacol (2012) 0.92
IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy. J Interferon Cytokine Res (2010) 0.88
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection. J Gastroenterol Hepatol (2012) 0.86
Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients. Inflammopharmacology (2012) 0.86
Serotonin: a double-edged sword for the liver? Surgeon (2011) 0.83
5-HT(1A) receptor and apoptosis contribute to interferon-α-induced "depressive-like" behavior in mice. Neurosci Lett (2012) 0.83
Symptomatic treatment of interferon-α-induced depression in hepatitis C: a systematic review. J Clin Psychopharmacol (2012) 0.83
Effect of interferon-α on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy study. Psychol Med (2013) 0.83
Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs. J Affect Disord (2011) 0.81
Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis. Int J Clin Pract (2013) 0.79
Norepinephrine inhibits human immunodeficiency virus type-1 infection through the NF-kappaB inactivation. Virology (2005) 0.79
Sustained virological response in the antiviral therapy of chronic hepatitis C: is there a predictive value of interferon-induced depression? Chemotherapy (2007) 0.78
Interferon-alpha Treatment of Hepatitis C Patients With Psychiatric Illness: Evidence-Based Risk-Benefit Assessment. Prim Care Companion J Clin Psychiatry (2005) 0.77
Retrospective chart review to assess the relationship between depression and sustained virological response from interferon treatment for hepatitis C virus. Clin Ther (2011) 0.77
Pre-treatment waking cortisol response and vulnerability to interferon α induced depression. Eur Neuropsychopharmacol (2012) 0.76
Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis. Psychosomatics (2013) 0.76
Retracted Attachment styles, pain, and the consumption of analgesics during labor: a prospective observational study. J Pain (2014) 1.07
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C. Psychiatry Res (2017) 0.75
HCV triple therapy in co-infection HIV/HCV is not associated with a different risk of developing major depressive disorder. J Int AIDS Soc (2014) 0.75